Medicine and Dentistry
Rheumatoid Arthritis
100%
Magnetic Resonance Imaging
75%
Disease Activity
39%
Disease-Modifying Antirheumatic Drug
27%
Adalimumab
25%
Ankylosing Spondylitis
25%
Spondylarthritis
25%
Randomized Clinical Trial
25%
Diseases
25%
Cohort Study
25%
HLA-B27
25%
Hand Bone
25%
TNF Inhibitor
25%
Biological Product
25%
Osteolysis
25%
Methotrexate
25%
Odds Ratio
17%
DAS28
12%
Osteitis
11%
Disease Modifying Antirheumatic Drug
11%
C Reactive Protein
10%
Bone Density
10%
Public Health
8%
Severe Asthma
8%
Disease Process
8%
Cohort Effect
8%
Disease Severity
8%
Chronic Rhinosinusitis
8%
Chronic Urticaria
8%
Atopic Dermatitis
8%
Rhinitis
8%
Asthma
8%
Clinical Trial
7%
Simplified Disease Activity Index
7%
Combination Therapy
5%
Triamcinolone
5%
Tenosynovitis
5%
Keyphrases
Rheumatologists
25%
Ultrasound Examination
25%
Tenosynovitis
25%
MeDALL
25%
GA2LEN
25%
Uniform Approach
25%
Osteitis
25%
Synovitis
25%
Conventional DMARDs
25%
Non-radiographic Axial Spondyloarthritis
25%
Established Rheumatoid Arthritis
25%
US Examination
12%
Patient Outcomes
12%
Examination Techniques
12%
Standardized Examinations
12%
Digital X-ray Radiogrammetry
10%
Bone Erosion
8%
Severe Asthma
8%
Comorbid Factors
8%
Activity Control
8%
Disease Concept
8%
Change Score
8%
Bone Joint
8%
Chronic Urticaria
8%
Treatment Responsiveness
8%
Joint Space Narrowing
8%
Severe Exacerbations
8%
Rhinitis
8%
Novel Therapies
8%
Radiographic Damage
6%
Sharp Score
5%
Early RA
5%
Hand Radiographs
5%
Treatment-naïve
5%
Axial Spondyloarthritis (AxSpA)
5%
Pharmacology, Toxicology and Pharmaceutical Science
Rheumatoid Arthritis
50%
Remission
25%
Methotrexate
25%
Adalimumab
25%
Biological Product
25%
Disease Modifying Antirheumatic Drug
20%
Disease Activity
20%
Osteitis
16%
Inflammation
16%
Clinical Trial
9%
Disease Activity Score
8%
Chronic Urticaria
6%
Chronic Rhinosinusitis
6%
Rhinitis
6%
Triamcinolone
5%
